Title:

MannKind at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference Transcript

Price:$54.00
Publication Date:Feb 06, 2008
Source:Thomson StreetEvents
Company:MannKind
Report Type:Transcript
Abstract:Final Transcript of MNKD presentation, 6-Feb-08 1:40pm ET
Brief Excerpt:... - Merrill Lynch - Analyst Welcome to this afternoon's presentation by MannKind Pharmaceuticals. MannKind, as many of you know, has got Technosphere insulin in late-stage development and we're expecting pivotal data to show up in the next several months, perhaps as soon as the first half of this year and it looks like the product has some extremely interesting product profiles that could be a step forward in the treatment of diabetes. To tell us about the story, we've got Al Mann, Chairman and CEO and Dick Anderson who is the Chief Financial Officer. And with that, to you. ...
Word Count:6383
Length:10 Pages
Ticker:MNKD
Time:1:40pm ET
Related Report(s):
Format:Adobe Acrobat Adobe Acrobat
Free Sample: Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"

 
Purchase Report
Price: $54.00




Thomson StreetEvents

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

  about us contact us public company index private company index pcan widget your privacy rights terms & conditions